An allosteric DNAzyme-Based logic circuit intelligent electrochemiluminescence biosensor for the precise diagnosis of acute myocardial infarction
Biosensors and Bioelectronics · 2026
DOI: 10.1016/j.bios.2025.118245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026. Verfasst von Zhe Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Anhui University of Technology, Ma'anshan, Anhui, 243032, PR China. Hauptthemen laut MEDLINE: Biosensing Techniques, DNA, Catalytic, Myocardial Infarction, MicroRNAs. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Natural Science Foundation of Anhui Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Acute myocardial infarction (AMI) is a life-threatening medical emergency that requires early diagnosis and prompt intervention. However, distinguishing AMI from other coronary artery diseases with similar clinical manifestations remains challenging. In this study, a novel electrochemiluminescence (ECL) biosensor was developed by integrating allosteric DNAzyme nanodevices with ECL resonance energy transfer (ECL-RET) probes to enable intelligent analysis of multiple miRNAs related to different coronary artery diseases. A series of DNA-based logic devices was constructed by integrating strand displacement reactions into a DNAzyme framework, including YES, AND, OR, and INHIBIT logic gates. The "INHIBIT-AND" logic circuits, which perform complex information processing, can effectively analyze multiple miRNAs and intelligently differentiate diseases similar to AMI. The final signal was detected using an ECL-RET probe synthesized by encapsulating Ru[(bpy)3]2+ reductive-oxidative (R-O) emitters and CdTe quantum dots (QD) oxidative-reductive (O-R) emitters into DNA-modified silica nanoparticles. The sensing platform can intelligently detect multiple miRNAs, with a detection limit of 62 aM (S/N = 3), ranging from 1 fM to 1 nM. This strategy was applied to patients' serum samples, providing a new idea for the autonomous and precise diagnosis of AMI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Anhui University of Technology, Ma'anshan, Anhui, 243032, PR China.
- School of Chemistry and Chemical Engineering, Anhui University of Technology, Ma'anshan, Anhui, 243032, PR China; Anhui Province Key Laboratory for Control and Applications of Optoelectronic Information Materials, Schoo…
- State Key Laboratory of Chemistry and Utilization of Carbon-Based Energy Resources, College of Chemistry, Xinjiang University, Urumqi, 830017, PR China. Electronic address: zhangkui@mail.ustc.edu.cn.
Förderung
- Natural Science Foundation of Anhui Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Z., Dai, Y., Liu, J., Zhou, Y., Du, Z., Zhu, R., Xu, C., Sun, Y., & Zhang, K. (2026). An allosteric DNAzyme-Based logic circuit intelligent electrochemiluminescence biosensor for the precise diagnosis of acute myocardial infarction. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2025.118245
Vancouver
Zhang Z, Dai Y, Liu J, Zhou Y, Du Z, Zhu R, et al. An allosteric DNAzyme-Based logic circuit intelligent electrochemiluminescence biosensor for the precise diagnosis of acute myocardial infarction. Biosensors and Bioelectronics. 2026. doi:10.1016/j.bios.2025.118245
BibTeX
@article{Zhang2026,
author = {Zhang, Zhe and Dai, Yao and Liu, Jinhua and Zhou, Yajie and Du, Zhongdi and Zhu, Runze and Xu, Cheng and Sun, Yudie and Zhang, Kui},
title = {An allosteric DNAzyme-Based logic circuit intelligent electrochemiluminescence biosensor for the precise diagnosis of acute myocardial infarction},
journal = {Biosensors and Bioelectronics},
year = {2026},
doi = {10.1016/j.bios.2025.118245}
}
EUVIMED